Evidence map›Paper›PMID 37491085›Full record

ArticleBMJ open2023

Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study.

Carlos Solano, Pedro Castro-Rebollo, Antonio Pérez-Martínez, Lucia López-Corral, Pere Barba-Suñol, Mi Kwon, Valentín Ortiz, Jaime Sanz-Caballer, Ana Carolina Caballero, Joaquín Martínez and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 1 country.

Carlos SolanoDepartment of Hematology, Institute for Research (INCLIVA), Hospital Clínico Universitario, Valencia, Spain carlos.solano@uv.es.ORCID 0000-0003-3702-0817
Pedro Castro-RebolloMedical Intensive Care Unit, Hospital Clinic de Barcelona, Barcelona, Spain.
Antonio Pérez-MartínezPediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
Lucia López-CorralHematology Service, Hospital Clínico Universitario de Salamanca, Salamanca, Spain.
Pere Barba-SuñolHematology Service, Vall d'Hebron University Hospital, Barcelona, Spain.
Mi KwonHematology Service, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Valentín OrtizHematology Service, Clinic Barcelona Hospital University, Barcelona, Spain.
Jaime Sanz-CaballerHematology Service, Hospital La Fe, Valencia, Spain.
Ana Carolina CaballeroGrupo de Inmunoterapia celular y Terapia Génica (GITG), Clinical Hematology Service, Hospital de Sant Pau, Barcelona, Spain.
Joaquín MartínezHematology Service, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ángel CedilloSpanish Group for Hematopoietic Transplantation and Cell Therapy, Madrid, Spain.
Anna SuredaClinical Hematology Service, Institut d'Investigacio Biomedica de Bellvitge, Barcelona, Spain.
Hospital Clínic de Barcelona · ESComplejo Hospitalario de Salamanca · ESHospital de Sant Pau · ESHospital General Universitario Gregorio Marañón · ESHospital Universitario 12 De Octubre · ESHospital Universitario La Paz · ESInstitut d'Investigació Biomédica de Bellvitge · ESSpanish Society of Hematology and Hemotherapy · ESUniversitat de València · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo estimate the readiness of Spanish National Health Service (NHS) hospitals to provide chimeric antigen receptor T cell (CAR-T), and to identify and quantify the different resources needed to provide CAR-T considering three scenarios defined by 10, 25 and 50 patients per centre per year.

designTargeted literature review and quantitative study using a questionnaire and telephone interviews. An algorithm was created to determine hospitals' readiness based on their capacity and capability. All the requirements for quantification were assessed and validated by the steering committee, formed by members of the Spanish Group of Haematopoietic Transplantation and Cell Therapy. A weighting system (from 0 to 1) was established for capability quantification. For resources quantification, a scoring system was established, with 0 points representing the minimum and 3 points the maximum of additional resources that a hospital indicated necessary.

setting40 Spanish hospital centres that perform allogeneic haematopoietic stem cell transplantation were invited to complete the questionnaire for capacity quantification, 28 of which provided valid responses. Nine hospitals participated in the interviews for resource quantification, eight of which had previously been designated by the Ministry of Health (MoH) to provide CAR-T. OUTCOME MEASURE: Current capacity of NHS Spanish sites to administer CAR-T under different theoretical scenarios with varying numbers of procedures, and the potential healthcare resources that would be needed to realise the theoretical capacity requirements.

resultsFour hospitals were optimally ready, 17 were somewhat ready and 7 were not ready. The actual extrapolated capacity of the currently designated MoH CAR-T sites would allow treatment of approximately 250 patients per year. Regarding healthcare resource needs, the numbers of haematologists, nurses and beds were the most important limiting factors, and those requiring further growth as patient numbers increased.

conclusionsIncreasing the number of CAR-T-qualified centres and/or increasing resources in the current designated sites are two potential strategies that should be considered to treat CAR-T-eligible patients in Spain.

Indexed as

Receptors, Chimeric AntigenHospitalsHumansImmunotherapy, AdoptiveSpainState MedicineReceptors, Chimeric Antigenhaematologyleukaemialymphomaorganisation of health servicestherapeutics

Identifiers

PMID37491085
PMCPMC10373688
OpenAlexW4385246948

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.